Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd. Is a high-tech enterprise for peptides, which is called Tianji for short in this introduction. Established in June 2000, Tianji has 290 employees now, in which 34 percent have college degrees, and 13 percent are chemists for R&D.
Focusing on the research and development of pharmaceuticals for immunity adjustment, anti-inflammatory, analgesic, antibiotics, and anticancer, Tianji has one GMP workshop for peptide APIs production, and three GMP workshops for injections and freeze-dried powder injections.
so far, the platform for new drug development, the platform for peptides custom synthesis and manufacturing and the platform for protected amino acids synthesis have been established. Meanwhile, cooperating with several universities, the R&D center for finished dosages is one of the key centers in Suzhou.

There are chemical synthesis labs, peptides synthesis labs(solid phase synthesis & liquid phase synthesis), peptides purification labs, analysis labs, rotary evaporation labs, and lyophilization labs in the R&D center. Elite preparative HPLC system, Varian SD1 RPLC, peptide solid phase synthesis reactors with 100L volume and 200L volume, RPLCs with 15cm column and 20cm column, BUCHI rotary evaporation with 2L volume and 20L volume, Dionexd LC/MS, and Agilent LC/MS are available in our R&D center.